Alterity Therapeutics Ltd (ATHE) stock
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
$1.86−0.09 (-4.85%)
Close on Nov 17, 2026Market cap $33.80MP/E –Yield –
Alterity Therapeutics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Alterity Therapeutics
Alterity Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?